Markets

Drilling Down Into the Books for Pernix Therapeutics Holdings, Inc. (PTX)

It is interesting to note that Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) is active and made a solid movement in the last trading day. Now trading with a market value of 6.97M, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For PTX, the company currently has 24.51 million of cash on the books, which is offset by 0 in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 0 in total assets, balanced by 172.28 million in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Pernix Therapeutics Holdings, Inc. saw 0 in free cash flow last quarter, representing a quarterly net change in cash of 25.53 million. Perhaps most importantly where cash movements are concerned, the company saw about 0 in net operating cash flow.

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 37.16 million in total revenues. That represents a quarterly year/year change in revenues of -0.09% in sequential terms, the PTX saw sales grow by 0.43%.



But what about the bottom line? After all, that’s what really matters in the end. Pernix Therapeutics Holdings, Inc. is intriguing when broken down to its core data. The cost of selling goods last quarter was 11.82 million, yielding a gross basic income of 25.33 million. For shareholders, given the total diluted outstanding shares of 15.84M, this means overall earnings per share of -890.

Previous ArticleNext Article

Related Post

Yelp Inc. (YELP) Raising Eyebrows Among Investors Yelp Inc. (NYSE:YELP) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 2.81B, the compa...
Drilling Down Into the Books for Fitbit, Inc. (FIT... Fitbit, Inc. (NYSE:FIT)'s interesting series of developments are underway around the US stock market these days. Now trading with a market value of 1....
Comcast Corporation (CMCSA): More In-Depth Monitor... Comcast Corporation (NASDAQ:CMCSA) is in the highlights and many would want to know whether now might be a good time for it to present much upside. No...
Weatherford International plc (WFT): Checking the ... Weatherford International plc (NYSE:WFT) is an interesting stock at present. Now trading with a market value of 614.30M, the company has a mix of cata...
Taking a Look at the Operational Data for Texas In... Texas Instruments Incorporated (NASDAQ:TXN)'s interesting series of developments are underway around the US stock market these days. Now trading with ...